Antimicrobial Agents Practice Questions

Q: All of the following are sulphonamides used topically except.

Sulphadiazine. ***Sulphadiazine*** - **Sulphadiazine** itself is primarily used for **systemic infections** such as toxoplasmosis, often in combination with pyrimethamine. - While it is a **sulfonamide**, it is not formulated for **topical application** in its uncombined form. *Sulphacetamide* - **Sulphacetamide** is commonly used as an **ophthalmic solution** or ointment to treat bacterial **conjunctivitis** and other eye infections. - It is well-suited for **topical application** due to its good tissue penetration and antimicrobial activity against common eye pathogens. *Silver sulphadiazine* - **Silver sulphadiazine** is a widely used **topical cream** for the prevention and treatment of **burn wound infections**. - The combination of **silver ions** and sulphadiazine provides broad-spectrum **antimicrobial activity** against bacteria and fungi in open wounds. *Mafenide* - **Mafenide** is a powerful **topical sulfonamide** primarily used to prevent and treat bacterial **infections in burns**. - It is known for its ability to penetrate **eschar** (necrotic tissue) effectively, making it valuable in deep burn wound management.

Q: Which of the following drugs is useful in the prophylaxis of meningococcal meningitis?

Rifampin. ***Rifampin*** - **Rifampin** is the **first-line agent** for **chemoprophylaxis** of meningococcal meningitis according to CDC guidelines. - Administered as **600 mg twice daily for 2 days** (adults) or **10 mg/kg twice daily for 2 days** (children). - Works by inhibiting bacterial RNA polymerase, achieving excellent penetration into respiratory secretions to eliminate nasopharyngeal carriage of **Neisseria meningitidis**. - Recommended for close contacts of index cases to prevent secondary transmission. *Doxycycline* - **Doxycycline** is **not recommended** for meningococcal prophylaxis in current guidelines. - While it has some activity against Neisseria meningitidis, it is not included in CDC or WHO recommendations due to inconsistent efficacy and the availability of more effective alternatives. - Tetracyclines are not first-line agents for this indication. *Minocycline* - **Minocycline** was historically used for meningococcal prophylaxis but is **no longer recommended**. - Significant side effects including **vertigo, dizziness**, and **ataxia** limit its use. - It has been replaced by safer and more effective alternatives like rifampin and ciprofloxacin. *Cephalexin* - **Cephalexin** is a first-generation cephalosporin used primarily for **skin, soft tissue**, and some **urinary tract infections**. - It is **not effective** against **Neisseria meningitidis** and has **no role** in meningococcal meningitis prophylaxis. - Note: **Ceftriaxone** (third-generation cephalosporin) is an alternative for prophylaxis, but cephalexin is not.

Q: Which of the following is not an antipseudomonal antibiotic?

Cephalexin. ***Cephalexin*** - **Cephalexin** is a **first-generation cephalosporin** primarily active against **Gram-positive** bacteria and some Gram-negative organisms, but it lacks activity against *Pseudomonas aeruginosa* [1]. - **First-generation cephalosporins** are generally not effective against **Gram-negative bacteria** resistant to earlier beta-lactams, such as *Pseudomonas*. *Carbenicillin* - **Carbenicillin** is a **carboxypenicillin** that specifically targets **Pseudomonas aeruginosa**, making it an effective antipseudomonal agent. - It was one of the **first penicillin derivatives** developed with substantial activity against *Pseudomonas* and other difficult-to-treat Gram-negative bacteria. *Piperacillin* - **Piperacillin** is a **ureidopenicillin** (extended-spectrum penicillin) known for its robust activity against **Pseudomonas aeruginosa**. - Often combined with a **beta-lactamase inhibitor** like **tazobactam** (as in **piperacillin/tazobactam**) to broaden its spectrum and prevent enzymatic degradation, further enhancing its antipseudomonal efficacy. *Ceftazidime* - **Ceftazidime** is a **third-generation cephalosporin** celebrated for its **excellent activity** against **Pseudomonas aeruginosa** and other Gram-negative bacteria [2]. - Unlike many other third-generation cephalosporins, its primary strength lies in its **antipseudomonal coverage**, making it a key choice for serious *Pseudomonas* infections.

Q: Which of the following antibiotics is the drug of choice for Gram-negative anaerobes?

Metronidazole. ***Metronidazole*** - **Metronidazole** is highly effective against most **Gram-negative anaerobic bacteria**, including *Bacteroides fragilis*, a common pathogen in intra-abdominal infections and abscesses. - It works by forming **nitro-radicals** that damage microbial DNA, exhibiting potent **bactericidal action** against anaerobes. *Aztreonam* - **Aztreonam** is a **monobactam** antibiotic with a narrow spectrum of activity, primarily targeting **Gram-negative aerobic bacteria** (e.g., *Pseudomonas aeruginosa*). - It is **inactive against Gram-positive bacteria** and **anaerobes**, making it unsuitable for Gram-negative anaerobic infections. *Doxycycline* - **Doxycycline** is a **tetracycline antibiotic** with broad-spectrum activity against many Gram-positive and Gram-negative **aerobic** and some anaerobic organisms. - While it has some anaerobic activity, it is **not the drug of choice for significant Gram-negative anaerobic infections** due to resistance patterns and the superior efficacy of metronidazole. *Vancomycin* - **Vancomycin** is primarily used for **Gram-positive bacterial infections**, especially those resistant to other antibiotics like methicillin-resistant *Staphylococcus aureus* (**MRSA**). - It has **no activity against Gram-negative bacteria**, **aerobic or anaerobic**, as its large molecular size prevents penetration of the outer membrane.

Q: Second-generation cephalosporin that can be used orally is:

Cefaclor. ***Cefaclor*** - **Cefaclor** is a commonly used **second-generation cephalosporin** that is available in an **oral formulation**, making it suitable for outpatient treatment of various bacterial infections. - Its spectrum of activity includes many Gram-positive and Gram-negative bacteria, often used for **respiratory tract infections** and **otitis media**. *Cefepime* - **Cefepime** is a **fourth-generation cephalosporin**, not a second-generation one, and is primarily administered **intravenously** for severe infections. - It has a broader spectrum against both Gram-positive and Gram-negative bacteria, including **Pseudomonas aeruginosa**. *Cefalothin* - **Cefalothin** (also known as cephalothin) is a **first-generation cephalosporin** that is typically administered **parenterally** (intravenously or intramuscularly). - It is not available in an oral formulation, limiting its use to hospital settings for moderate to severe infections. *Cefadroxil* - **Cefadroxil** is a **first-generation cephalosporin** and is available for oral administration. - While it is an oral cephalosporin, it belongs to the first generation, not the second generation as requested by the question.

Q: Which class of antibiotics is primarily inactivated by extended-spectrum β-lactamases (ESBLs)?

Third-generation cephalosporins. ***Third-generation cephalosporins*** - **ESBLs** are a group of enzymes primarily known for their ability to hydrolyze and inactivate **third-generation cephalosporins** (e.g., ceftriaxone, ceftazidime) and other beta-lactam antibiotics. - This inactivation mechanism renders agents like **ceftriaxone ineffective** against bacteria producing these enzymes, leading to significant treatment challenges. *Macrolides* - **Macrolides** (e.g., azithromycin, erythromycin) act by **inhibiting bacterial protein synthesis** through binding to the 50S ribosomal subunit. - Their mechanism of action is distinct from beta-lactam antibiotics, and they are generally **not inactivated by ESBL enzymes**. *Quinolones* - **Quinolones** (e.g., ciprofloxacin, levofloxacin) primarily function by **inhibiting bacterial DNA gyrase and topoisomerase IV**, thereby preventing DNA replication. - **ESBLs do not target quinolones**; resistance to quinolones typically arises from mutations in gyrase or efflux pump mechanisms. *Aminoglycosides* - **Aminoglycosides** (e.g., gentamicin, amikacin) are bactericidal antibiotics that **bind to the 30S ribosomal subunit**, interfering with protein synthesis. - While resistance to aminoglycosides can occur through modifying enzymes, **ESBLs do not inactivate this class of antibiotics**.

Q: Which of the following antifungal agents is used in combination therapy for cryptococcal meningitis?

Flucytosine. **Flucytosine** - **Flucytosine** is commonly used in combination with **amphotericin B** for the initial treatment of **cryptococcal meningitis** [1][2][3]. - This combination therapy allows for synergy, improving efficacy and potentially reducing the dosage and toxicity of amphotericin B [1]. *Nystatin* - **Nystatin** is an antifungal agent primarily used for topical or oral treatment of **mucocutaneous candidiasis**. - It is not systemically absorbed and therefore ineffective for invasive infections like **cryptococcal meningitis**. *Terbinafine* - **Terbinafine** is an antifungal drug mainly used to treat **dermatophyte infections**, such as athlete's foot and onychomycosis [2]. - Its mechanism of action targets fungal ergosterol synthesis at an early stage, which is not suitable for treating **cryptococcal meningitis**. *Voriconazole* - **Voriconazole** is a broad-spectrum azole antifungal used for severe invasive fungal infections, including **aspergillosis** and **candidiasis** [2]. - While it has some activity against *Cryptococcus*, it is not the preferred or standard agent for initial combination therapy for **cryptococcal meningitis**, for which amphotericin B and flucytosine are typically used [2].

Q: Which of the following drugs is NOT considered a first-line treatment for candidiasis?

Caspofungin. ***Caspofungin*** - Caspofungin is an **echinocandin** that, while highly effective against *Candida*, is **not typically used as initial therapy** for common candidal infections such as **oral thrush** or **vulvovaginal candidiasis**. - It is generally reserved for **invasive candidiasis** in hospitalized patients or when **azoles are ineffective or contraindicated**. - Its use is limited by **intravenous-only administration**, higher cost, and reserve status for serious infections. *Fluconazole* - **Fluconazole** is the **first-line azole antifungal** for most forms of candidiasis, including **oropharyngeal, esophageal, and vulvovaginal candidiasis**. - Its excellent **oral bioavailability**, favorable side effect profile, and proven efficacy make it the preferred initial treatment in most clinical settings. *Nystatin* - **Nystatin** is a **polyene antifungal** widely used as **first-line therapy** for **localized mucocutaneous candidiasis**, particularly **oral thrush** (as swish-and-swallow suspension) and cutaneous infections. - Its topical action, minimal systemic absorption, and excellent safety profile make it ideal for superficial candidal infections. *Amphotericin B* - **Amphotericin B** is a **broad-spectrum polyene antifungal** with potent fungicidal activity, but it is **not routinely used as first-line therapy** for most candidiasis due to significant toxicity (nephrotoxicity, infusion reactions). - While historically used for severe infections, current guidelines favor **echinocandins or azoles as first-line agents** for invasive candidiasis, with Amphotericin B reserved for resistant cases or specific clinical situations. - Its use as initial therapy is primarily considered when other agents cannot be used due to resistance or contraindications.

Q: Which oral drug combination is recommended as first-line treatment for uncomplicated malaria caused by chloroquine-resistant *P. falciparum*?

Artemether-Lumefantrine. ***Artemether-Lumefantrine*** - **Artemether-Lumefantrine (AL)** is a WHO-recommended **Artemisinin-based Combination Therapy (ACT)** and the most widely used first-line treatment for uncomplicated **chloroquine-resistant *P. falciparum* malaria**. - The combination provides **rapid parasite clearance** (artemether) and **prevents recrudescence** (lumefantrine), with excellent efficacy and tolerability. - It is administered as a **3-day oral regimen** and is suitable for use in most endemic regions. *Artesunate-Mefloquine* - While **Artesunate-Mefloquine** is also a WHO-recommended ACT and effective against chloroquine-resistant malaria, it is less commonly used than Artemether-Lumefantrine due to **mefloquine's neuropsychiatric side effects** (dizziness, anxiety, sleep disturbances). - It is primarily used in regions where other ACTs have reduced efficacy, particularly in **Southeast Asia**. *Quinine plus Doxycycline* - **Quinine plus Doxycycline** is an effective combination but is generally considered a **second-line treatment** due to quinine's **poor tolerability** and **complex 7-day dosing regimen**. - **Side effects** include **cinchonism** (tinnitus, headache, nausea) and **cardiac arrhythmias**, limiting its use as first-line therapy. - Doxycycline is contraindicated in **pregnancy** and **children under 8 years**. *Atovaquone-Proguanil* - **Atovaquone-Proguanil (Malarone)** is highly effective and well-tolerated but is **expensive** and primarily used for **prophylaxis** or treatment in **travelers** from non-endemic countries. - It is not recommended as first-line treatment in endemic regions due to **cost considerations** and limited availability.

Q: Which of the following statements about cephalosporins is false?

Active against only gram-positive bacteria. ***Active against only gram-positive bacteria*** - This statement is **false** because later generations of cephalosporins, especially third and fourth generations, have significant activity against **gram-negative bacteria**. - While earlier generations had a stronger gram-positive spectrum, **cephalosporins** as a class are not limited to gram-positive bacteria. *Bactericidal agents* - Cephalosporins are indeed **bactericidal** agents, meaning they kill bacteria rather than just inhibiting their growth. - They achieve this by interfering with **bacterial cell wall synthesis**, specifically by binding to penicillin-binding proteins (PBPs). *Ceftriaxone is administered via injection.* - **Ceftriaxone** is a third-generation cephalosporin commonly administered via **intramuscular or intravenous injection**. - Its long half-life allows for once-daily dosing, making it a convenient option for parenteral treatment. *Third-generation cephalosporins are resistant to certain beta-lactamases from gram-negative bacteria.* - Third-generation cephalosporins were developed to have increased stability against many common **beta-lactamases produced by gram-negative bacteria**, a significant advantage over earlier generations. - This resistance improves their efficacy against a broader range of gram-negative pathogens, although some newer **extended-spectrum beta-lactamases (ESBLs)** can still inactivate them.

Question 1

All of the following are sulphonamides used topically except.

Accepted Answer

Sulphadiazine

Answer

Silver sulphadiazine

Answer

Mafenide

Answer

Sulphacetamide

Question 2

Which of the following drugs is useful in the prophylaxis of meningococcal meningitis?

Accepted Answer

Rifampin

Answer

Doxycycline

Answer

Minocycline

Answer

Cephalexin

Question 3

Which of the following is not an antipseudomonal antibiotic?

Accepted Answer

Cephalexin

Answer

Piperacillin

Answer

Ceftazidime

Answer

Carbenicillin

Question 4

Which of the following antibiotics is the drug of choice for Gram-negative anaerobes?

Accepted Answer

Metronidazole

Answer

Vancomycin

Answer

Aztreonam

Answer

Doxycycline

Question 5

Second-generation cephalosporin that can be used orally is:

Accepted Answer

Cefaclor

Answer

Cefepime

Answer

Cefalothin

Answer

Cefadroxil

Question 6

Which class of antibiotics is primarily inactivated by extended-spectrum β-lactamases (ESBLs)?

Accepted Answer

Third-generation cephalosporins

Answer

Macrolides

Answer

Quinolones

Answer

Aminoglycosides

Question 7

Which of the following antifungal agents is used in combination therapy for cryptococcal meningitis?

Accepted Answer

Flucytosine

Answer

Nystatin

Answer

Terbinafine

Answer

Voriconazole

Question 8

Which of the following drugs is NOT considered a first-line treatment for candidiasis?

Accepted Answer

Caspofungin

Answer

Nystatin

Answer

Amphotericin B

Answer

Fluconazole

Question 9

Which oral drug combination is recommended as first-line treatment for uncomplicated malaria caused by chloroquine-resistant *P. falciparum*?

Accepted Answer

Artemether-Lumefantrine

Answer

Quinine plus Doxycycline

Answer

Artesunate-Mefloquine

Answer

Atovaquone-Proguanil

Question 10

Which of the following statements about cephalosporins is false?

Accepted Answer

Active against only gram-positive bacteria

Answer

Ceftriaxone is administered via injection.

Answer

Bactericidal agents

Answer

Third-generation cephalosporins are resistant to certain beta-lactamases from gram-negative bacteria.

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?